Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a new revision number (v3.6.3) replacing the previous v3.6.2. This represents a minor metadata update to the Study Details page.SummaryDifference0.1%

- Check27 days agoChange DetectedThe study materials on the page were updated to Revision: v3.6.2, replacing the previous v3.6.0, indicating a newer protocol/document version for the trial.SummaryDifference0.1%

- Check41 days agoChange DetectedRecruitment status shows no current enrollment; new guidance sections were added and header formatting updated, with a new revision tag (v3.6.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor version update to the page.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a new published revision of the page content. This change represents an update to the page's version metadata rather than a modification to the substantive study information.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page’s revision/version number was incremented from v3.5.2 to v3.5.3, reflecting a non-content site update.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.